What type of study is this?

This is a Observational study (also classified as: In Vitro Study).

September 14, 2025

Human Coronavirus-229E Hijacks Key Host-Cell RNA-Processing Complexes for Replication.

View Full Paper

Ask AI

Bookmark

Authors

High-throughput structural proteomics reveals HCoV-229E hijacks RNA-processing pathways, suggesting therapeutic targets.

HCoV-229E effectively replicates by hijacking key RNA-processing pathways, impacting host cell functions.
The study identified that modulation of specific RNA complexes can significantly attenuate HCoV-229E replication.
Limited proteolysis-based mass spectrometry allowed for capturing protein conformational changes critical for understanding virus-host interactions.
Identifying these therapeutic targets could provide a broad efficacy approach to combating coronavirus infections.

Sarkar et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark